ArticleBMC plant biology2026
Physiological and morphological responses of strawberry seedlings to end-of-day far-red light.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe agronomic quality of cutting-propagated strawberry seedlings is a critical determinant of subsequent field performance and economic returns in the annual production of fresh-market strawberries. Although far-red light (FR) has been well established as a key regulator of plant architecture and productivity in many horticultural crops, its specific physiological roles during the strawberry seedling establishment stage remain poorly understood. Thus, investigating whether end-of-day far red (EOD-FR) light treatment can effectively enhance the growth vigor and overall development of strawberry runners addresses a significant knowledge gap, with direct implications for commercial seedling production systems.
methodsThe experiment investigated the effects of 0 (CK), 3 h, 6 h, and 9 h EOD-FR durations on strawberry cuttings (Fragaria × ananassa Duch. cv. Benihoppe). The 60-d period experiment was conducted in a solar greenhouse, employing a completely randomized block design. The sampling was carried at 30 d and 60 d to assess physiological and morphological responses of strawberry seedlings.
resultsCompared with the control (CK), 6 h EOD-FR supplementation markedly enhanced seedling growth, including increases in height, leaf area, petiole diameter and length, biomass accumulation, root development and vigor index. In addition, anatomical observations revealed that while prolonged EOD-FR exposure led to reduction in leaf thickness, the 6 h EOD-FR increased the number of vascular bundles in petioles and accelerated floral bud differentiation. The physiological analysis showed that 6 h EOD-FR supplementation enhanced net photosynthetic rate and stomatal conductance, and water use efficiency. This was observed alongside increased activities of antioxidant enzyme and greater accumulation of osmolytes, including free amino acids, soluble sugars, and proteins. Hormonal profiling indicated that 6 h EOD-FR increased the IAA, Brassinosteroids, and ABA levels in leaves and petioles. However, the marked increase of ABA content and reduce of GA₃ content were only found in shoot apices. Based on membership function values and principal component analysis, the order of treatment performance (6 h > 3 h > CK > 9 h) was consistent across both 30-d and 60-d experimental durations.
conclusionIn summary, supplementation with 6 h EOD-FR optimizes photosynthetic performance, strengthens antioxidant capacity, regulates hormone balance, and promotes nutrient accumulation in strawberry seedlings, ultimately leading to enhanced growth and stimulated floral induction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.